loredana g. marcu, phd - fizicaoradea.ro · 2016-09-23 · 5. l. marcu, e. bezak (editors) recent...

1

1. L. Marcu (editor) Contemporary Issues in Head and Neck Cancer Management InTech Publishing, ISBN: 978-953-51-2135-0 (2015)

2. S. Filip, L. Marcu Mechanics with applications in medicine University of Oradea Publisher, ISBN 978-606-10-1230-5, (Romanian language) (2014)

3. Loredana Marcu Applications of radiation physics in dosimetry and radioprotection University of Oradea Publisher, ISBN 978-606-10-1032-5, (Romanian language) (2013)

4. L. Marcu, E. Bezak, B. Allen

Biomedical physics in radiotherapy for cancer Springer Science, ISBN 978-0-85729-732-7 (March 2012) CSIRO Publishing, ISBN 978-0-643-09404-8 (Feb 2012)

5. L. Marcu, E. Bezak (editors)

Recent advances and research updates in medical physics and radiobiology International Research Promotion Council, Researchman Publ. ISBN 81-87424-11-7 (2011)

6. Loredana Marcu

The radiobiology of head and neck cancers University of Oradea Publisher, ISBN 978-973-759-626-0 (2008)

7. Loredana Marcu

Physics – Teaching methodology University of Oradea Publisher, ISBN 973-99416-57-0, (Romanian language) (1999)

8. S. Filip, L. Marcu

Mechanics University of Oradea Publisher, ISBN 973-98381-5-4, (Romanian language) (1998)

1. B. Allen, L. Marcu, E. Bezak, Targeted alpha therapy for cancer In: ed. D. Godfrey, J. Van Dyk, S. Das, B. Curran, A. Wolbarst, Advances in Medical Physics, vol 6, Medical Physics Publishing, Madison, Wisconsin, ISBN: 978-1-930524-90-3 (2016)

PUBLISHED BOOKS

LOREDANA G. MARCU, PhD

PUBLICATIONS &

CONFERENCE PRESENTATIONS

PUBLISHED BOOK CHAPTERS / JOURNAL SPECIAL ISSUES

2

2. L. Marcu, I. Toma-Dasu, A. Dasu

The 6 Rs of head and neck cancer radiotherapy In: ed. L. Marcu, Contemporary Issues in Head and Neck Cancer Management, InTech Publishing, ISBN: 978-953-51-2135-0 (2015)

3. L. Marcu, E. Bezak, I. Toma-Dasu, A. Dasu (editors) Predictive Models Of Tumour Response To Treatment Using Functional Imaging Techniques (Special issue journal) Computational and Mathematical Methods in Medicine, ISSN: 1748-670X (2015)

4. E. Bezak, L. Marcu, S. Penfold (editors) Computational and Mathematical Modeling of Tumor Kinetics and Response to Radiation and Chemotherapy (Special issue journal) Computational and Mathematical Methods in Medicine, ISSN: 1748-670X (2012)

5. L. Marcu, E. Yeoh

Tumour repopulation during treatment for head and neck cancer: clinical evidence, mechanisms and minimizing strategies In: ed. M. Agulnik, Head and Neck Cancer, InTech Publishing, ISBN: 978-953-51-0236-6 (2012)

6. E. Bezak, L. Marcu

Recent Advances in Brachytherapy: Overview and Brachytherapy for Specific Treatment Sites In: ed L. Marcu, E. Bezak, Recent advances and research updates in medical physics and radiobiology, International Research Promotion Council, Researchman Publ. ISBN 81-87424-11-7 (2011)

1. Loredana Marcu Radiobiology and radiation protection – on-line course for postgraduate students (http://www.physics.adelaide.edu.au/medical/RBPE.html) University of Adelaide, Australia (2005)

2. J. Patterson, L. Marcu

Aspects of basic physics – course guide for Dental School University of Adelaide, Medical School (2003)

3. S. Filip, E. Macocian, L. Marcu, C. Budasca et al,

General physics – laboratory guide for engineering students (Romanian language) University of Oradea (2000)

4. S. Filip, E. Macocian, L. Marcu, C. Budasca

Mechanics and acoustics – laboratory guide (Romanian language) University of Oradea (1997)

5. S. Filip, L. Marcu

Mechanics and acoustics – student textbook (Romanian language) University of Oradea (1997)

PUBLISHED TEXTBOOKS / LAB GUIDES FOR INTERNAL USE

3

1. L. Marcu, D. Marcu In silico modelling of a cancer stem cell-targeting agent and its effects on tumour control during radiotherapy Scientific Reports 6, 32332 (2016)

2. L. Marcu Future treatment directions for HPV-associated head and neck cancer based on radiobiological rationale and current clinical evidence Critical Reviews in Oncology/Hematology 103:27-36 (2016)

3. A. Santos, L. Marcu, C. Wong, E. Bezak Risk estimation of secondary primary cancers after breast radiotherapy Acta Oncologica (2016)

4. L. Marcu, D. Marcu, S. Filip In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy Cell Proliferation 49(3):304-314 (2016)

5. R. Chirla, L. Marcu PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer Physica Medica 32:23-35 (2016)

6. L. Marcu The first Rs of radiotherapy - or standing on the shoulders of giants Australasian Phys Eng Sci Med, 38(4):531-541 (2015)

7. L. Marcu, D. Marcu In silico evaluation of radiobiological hypoxia and its effect on tumour control during radiotherapy Proceedings of the 39th ARA Congress, Frascati, Rome, Italy, 28-31 July (2015)

8. E. Bezak, R. Takam, L. Marcu Peripheral photon and neutron doses from prostate cancer external beam irradiation Radiation Protection Dosimetry 167(4):591-601 (2015)

9. L. Marcu, D. Marcu, S. Filip In silico repopulation model of various tumour cells during treatment breaks in head and neck cancer radiotherapy World Academy of Science, Engineering and Technology, International Science Index, Medicine and Health Sciences 9(3) (2015)

10. M. Jennings, L. Marcu, E. Bezak PET-specific parameters and radiotracers in theoretical tumour modelling

Computational and Mathematical Methods in Medicine, Article ID 415923 (2015)

11. L. Marcu, W. Harriss-Phillips, S. Filip Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach Computational and Mathematical Methods in Medicine, Article ID 624642 (2014)

12. L. Marcu

ARTICLES PUBLISHED IN PEER REVIEWED INTERNATIONAL JOURNALS

4

Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy Cell Proliferation 47(4):318-325 (2014)

13. S. Sjostedt, E. Bezak, L. Marcu Experimental Investigation of the Cell Survival in Dose Cold Spot Acta Oncologica 53(1):16-24 (2014)

14. L. Marcu, A. Santos, E. Bezak Risk of second primary cancer after breast cancer treatment European Journal of Cancer Care 23(1):51-64 (2014)

15. L. Marcu Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments Biomed Research International 2013: 817279 (2013)

16. B. Allen, E. Bezak, L. Marcu Quo vadis radiotherapy? - Technological advances and the rising problems in cancer management Biomed Research International 2013: 749203 (2013)

17. L. Marcu, J. Lawson

Technical and dosimetric aspects of I-125 seed reimplantation in suboptimal prostate implants British Journal of Radiology 86:20130058 (2013)

18. L. Marcu, R. Gowda Comparison of three different post implant dosimetry methods following permanent I-125 prostate seed implants Medical Dosimetry 38:309-314 (2013)

19. T. Rutten, J. Lawson, L. Marcu Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution Physica Medica 29(6): 662-669 (2013)

20. E. Bezak, L. Marcu, S. Penfold Computational and Mathematical Modeling of Tumor Kinetics and Response to Radiation and Chemotherapy (editorial)

Computational and Mathematical Methods in Medicine 2012: 702675 (2012)

21. J. Moorrees, J. Lawson, L. Marcu Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy Radiation Oncology 7(1):196 (2012)

22. L. Moghaddasi, E. Bezak, L. Marcu Current challenges in Clinical Target Volume definition: tumour margins and microscopic extensions Acta Oncologica 51(8): 984-995 (2012)

23. S. Penfold, L. Marcu, J. Lawson, J. Asp

Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer Journal of Radiological Protection 32(3):339-347 (2012)

5

24. L. Marcu, J. Lawson, T. Rutten, R. Gowda

Quality indicators and technique for permanent I-125 prostate seed implants: 7 years post implant dosimetry evaluation Medical Physics 39(7) 4123 (2012)

25. L. Marcu, W. Harriss-Phillips

In Silico modelling of treatment-induced tumour cell kill: developments and advances Computational and Mathematical Methods in Medicine 2012:960256 (2012)

26. L. Marcu, E. Bezak

The influence of stem cell cycle time on accelerated repopulation during radiotherapy in head and neck cancer Cell Proliferation 45(5):404-412 (2012)

27. L. Moghaddasi, E. Bezak, L. Marcu

In Silico Modelling of Tumour Margin Diffusion and Infiltration Computational and Mathematical Methods in Medicine 2012: 672895 (2012)


Neoadjuvant cisplatin for head and neck cancer: simulation of a novel schedule for improved therapeutic ratio Journal of Theoretical Biology 297:41-47 (2012)

29. L. Marcu, E. Bezak, S. Filip

The role of PET imaging in overcoming radiobiological challenges in the treatment of advanced head and neck cancer Cancer Treatment Reviews 38:185-193 (2012)

30. R. Takam, E. Bezak, G. Liu, L. Marcu

The used of enriched 6Li and 7Li LiF:Mg,Cu,P glass-rod thermoluminescent dosimeters for linear accelerator-based out-of-field radiation dose measurements Radiation Protection Dosimetry 150(1): 22-33 (2012)

31. R. Takam, E. Bezak, L. Marcu, E. Yeoh

Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status. Radiation Research 176(4):508-520 (2011)

32. L. Marcu

Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain Cancer Treatment Reviews 36(8):606-614 (2010)


Modelling of tumour repopulation after chemotherapy Australasian Phys Eng Sci Med, 33(3):265-270 (2010)

34. R. Takam, E. Bezak, E. Yeoh, L. Marcu

Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models Medical Physics 37(9):5126-5137 (2010)

35. L. Marcu, E. Yeoh

The emerging role of predictive assays in the management of head and neck cancer Austral-Asian Journal of Cancer 9(2):71-77 (2010)

6


Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer Physica Medica: European Journal of Medical Physics 26(4):177-183 (2010)

37. L. Marcu, E. Bezak Radiobiological modelling of the interplay between accelerated repopulation and altered fractionation schedules in head and neck cancer Journal of Medical Physics 34:206-211 (2009)

38. L. Marcu, E. Yeoh A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment Journal of Cancer Research & Clinical Oncology 135(10):1303-1314 (2009)

39. L. Marcu

The role of scientific journals in disseminating cancer research in the 21st century (editorial) Austral-Asian Journal of Cancer 8(2) (2009)

40. L. Marcu

Cellular bystander effects and radiation hormesis Annals of the University of Oradea - Biology XVI / 1, pp. 66-70 (2009)

41. L. Marcu

The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy European Journal of Cancer Care 18:116-123 (2009)

42. W. Tuckwell, E. Bezak, E. Yeoh, L. Marcu

Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer Physics in Medicine and Biology 53:4489-4507 (2008)

43. R Takam, E. Bezak, E. Yeoh, L. Marcu

Assessment of normal tissue complications and second cancer risk following prostate cancer irradiation Austral-Asian Journal of Cancer 7:171-184 (2008)

44. L. Marcu

Science education: the need for an interdisciplinary approach Annals of the University of Oradea - Biology XIV:53-56 (2007)

45. L. Marcu, I. Olver

Tirapazamine: from bench to clinical trials Current Clinical Pharmacology 1:71-79 (2006)

46. L. Marcu, E. Bezak, I Olver

Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach Physics in Medicine and Biology 51:3625-3637 (2006)

47. L. Marcu, K Quach

The role of post-implant dosimetry in the quality assessment of prostate implants Australas Phys Eng Sci Med 29:1-5 (2006)

7

48. L. Marcu, T van Doorn, E. Bezak Determination of cell cycle phase-specific α parameters for squamous cell carcinomas of the head and neck Austral-Asian Journal of Cancer 5:157-165 (2006)

49. L. Marcu, E. Bezak, I. Olver, T van Doorn

Tumour resistance to cisplatin: a modelling approach Physics in Medicine and Biology 50:93-102 (2005)

50. L. Marcu, T van Doorn, I. Olver

Modelling of post irradiation accelerated repopulation in squamous cell carcinoma Physics in Medicine and Biology 49:3676-3779 (2004)

51. L. Marcu, AB Lyons, E. Bezak, T van Doorn

The onset of tumour repopulation after radiotherapy in theoretical and in vitro models Recent Advances and Research Updates 5:251-260 (2004) and in Austral-Asian Journal of Cancer 3:167-171 (2004)


Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer: a review of their cooperation Acta Oncologica 42:315-325 (2003)

53. L. Marcu, T van Doorn, I. Olver. S. Zavgorodni Growth of a virtual tumour using probabilistic methods of cell generation Australas Phys Eng Sci Med 25:155-161 (2002)

1. B. Allen, E. Bezak, L. Marcu, CY. Huang Quo vadis targeted radio-immunotherapy for metastatic prostate cancer? EPSM 2016, Sydney, Australia, 6-10 November (2016) (accepted)

2. P. Reid, P. Wilson, Y. Li, A. Staudacher, L. Marcu, E. Bezak Investigation of responses of HPV positive head and neck cancer stem cells under X-rays The 62nd Annual Meeting of the Radiation Research Society, Waikoloa, Hawaii, 16-19 October (2016) (accepted)

3. L. Marcu

Cancer stem cells – a new variable in the equation of tumour modelling? Karolinska Institutet, Stockholm, 18-24 Sept (2016) (Invited talk)

4. L. Marcu Photons – radiobiological issues related to the risk of second malignancies Workshop: Risk of secondary cancer following radiotherapy. Stockholm, 8-9 Sept (2016) (Invited talk)

5. L. Marcu, D. Marcu Radiobiological effects of cancer stem cell-targeting therapy in a head and neck cancer model Ist European Congress of Medical Physics (ECMP), Athens, 1-4 Sept (2016)

INTERNATIONAL CONFERENCES AND MEETINGS PRESENTATIONS

8

6. E. Bezak, L. Marcu Normal tissue complications in combined chemo-radiotherapy for head and neck cancer – a modelling approach MASCC Congress, Adelaide, 23-25 June (2016) (Invited talk)

7. L. Marcu Promises and challenges of cancer stem cell-targeting agents in the management of head and neck cancer Sansom Institute for Health Research, Division of Health Sciences, University of South Australia, Adelaide, 21 May – 3 June (2016) (Invited talk)

8. A. Dinu, T. Flonta, V. Virag, L. Marcu Comparative techniques of adaptive radiotherapy for locoregionally advanced oropharyngeal cancer The 7th AAMP Meeting (Alpe-Adria Medical Physics), Zagreb, 19-21 May (2016)

9. L. Marcu, D. Marcu, S. Filip The role of in silico modelling in radiotherapy optimisation and personalisation International Conference on Sciences, Oradea, 13-14 May (2016)

10. L. Marcu, D. Marcu Hyper- versus hypofractionated radiotherapy in a radioresistant head and neck cancer model ESTRO 35, Turin, Italy, 29 April – 3 May (2016)

11. L. Marcu In silico research towards optimisation of personalised treatment in head and neck cancer Conference of Diaspora in Scientific Research, Timisoara, Romania, 25-28 April (2016)

12. L. Marcu, D. Marcu, E. Bezak

Monte Carlo simulation of cancer stem cell-targeting agents and their effect on tumour control The 14th International Workshop on Radiation Damage to DNA, Melbourne, Australia, 20-24 March (2016)

13. L. Marcu, D. Marcu

Modeling the effect of symmetrical division of cancer stem cells on tumour response to radiation ICTR-PHE Conference, Geneva, Switzerland, 15-19 February (2016)

14. A. Santos, E. Bezak, L. Marcu Estimating the secondary primary cancer incidence after breast radiotherapy EPSM 2015, Wellington, New Zealand, 8-12 November (2015)

15. L. Marcu, D. Marcu In silico evaluation of radiobiological hypoxia and its effect on tumour control during radiotherapy

The 39th ARA Congress, Frascati, Rome, Italy, 28-31 July (2015)

16. L. Marcu, D. Marcu, S. Filip Cancer stem cells in a hierarchical model of tumour regrowth in five head and neck carcinomas World Congress on Medical Physics & Biomedical Engineering, Toronto, Canada, 7-12 June (2015)

17. A. Santos, E. Bezak, L. Marcu Risk estimate of second primary cancers after breast radiotherapy

9

World Congress on Medical Physics & Biomedical Engineering, Toronto, Canada, 7-12 June (2015)

18. L. Marcu Medical physics – or how a change in career path becomes a passion World Congress on Medical Physics & Biomedical Engineering, Toronto, Canada, 7-12 June (2015)

19. L. Marcu The impact of cancer stem cells (CSCs) on radiotherapy outcome: an in silico approach ACPESM WA Branch Meeting, Perth, Australia, 17-22 May (2015) (Invited talk)

20. L. Marcu, D. Marcu Monte Carlo simulation of personalised radiotherapy for head and neck cancer driven by tumour growth kinetics ICRR 2015, The 15th International Congress of Radiation Research, Kyoto, Japan, 25-29 May (2015)

21. L. Marcu, D. Marcu, S. Filip In silico repopulation model of various tumour cells during treatment breaks in head and neck cancer radiotherapy IEEE, International Conference on Radiation Medicine, Dubai, UAE, 11-12 March (2015)

22. D. Marcu, L. Marcu In silico growth of a hypoxic head and neck tumour including angiogenic processes The 60th Annual Meeting of the Radiation Research Society, Las Vegas, 21-24 Sept (2014)

23. L. Marcu The influence of repopulation mechanisms on treatment gap timing in head and neck cancer radiotherapy Workshop: Biological basis of radiotherapy – where do we stand? Stockholm, 4-5 Sept (2014)

24. L. Marcu, D. Marcu In silico simulation of tumour radiobiology towards individualised treatment The 3rd International Congress on Personalised Medicine (UPCP), Prague, 26-29 June (2014)

25. L. Marcu The effect of abortive division as a repopulation mechanism on head and neck cancer radiotherapy ESTRO 33, Vienna, Austria, 4-8 April (2014)

26. L. Marcu, D. Marcu, S. Filip, O. Straciuc The implementation of tumour-specific radiobiological parameters in a head & neck tumour growth model International Conference on Sciences, Baile Felix, 8-9 November (2013)

27. J. Moorrees, L. Marcu, J. Lawson Dosimetric evaluation of implant accuracy in low dose rate prostate brachytherapy with live-planning technique EPSM 2012, Gold Coast, Australia, 2-6 December (2012)

28. L. Moghaddasi, E. Bezak, L. Marcu

Geant4 beam model development for mathematical modelling of tumour microscopic extension EPSM 2012, Gold Coast, Australia, 2-6 December (2012)

10

29. L. Marcu, J. Lawson Dosimetric implications of I-125 seed brachytherapy in small volume prostates 3rd Romanian Conference on Medical Physics ECMP, Sibiu, 22-23 Sept (2012)

30. W. Harriss-Phillips, L. Marcu The effect of cisplatin and radiotherapy on a hypoxic head & neck tumour model

4th MOT (Modelling of Tumours) meeting, Adelaide, 2-4 August (2012)

31. L. Marcu, J. Lawson Dosimetric aspects of I-125 seed ‘top-up’ in suboptimal prostate implants World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 26-31 May (2012)

32. J. Moorrees, L. Marcu, J. Lawson

Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy World Congress on Medical Physics and Biomedical Engineering, Beijing, China, 26-31 May (2012)

33. E. Bezak, R. Takam, S. Bensaleh, E. K. Yeoh, L. Marcu

Normal Tissue Complication Probabilities in Prostate and Partial-Breast Irradiation Radiotherapy 6th Japan-Korea Joint Meeting on Medical Physics and Asia-Oceania Congress on Medical Physics, Fukuoka, Japan, 28 September – 1 October (2011).

34. L. Marcu

Functional Imaging for RT treatment planning: what diagnostic information can we gain: hypoxia, proliferation, metabolic activity? Summer School, Darwin, Australia, 12-13 August (2011) (invited lecture)

35. L. Marcu, J. Lawson, T. Rutten, R. Gowda

Quality indicators for permanent I-125 prostate seed implants: 7 years post implant dosimetry evaluation EPSM-ABEC 2011, Darwin, Australia, 14-18 August (2011)


Using Monte Carlo modelling in optimizing treatment outcome in advanced head and neck cancers treated with chemo-radiotherapy EPSM-ABEC 2011, Darwin, Australia, 14-18 August (2011)

37. T. Rutten, J. Lawson, L. Marcu

Dosimetry trends and treatment technique evolution over seven years of prostate brachytherapy at the Royal Adelaide Hospital EPSM-ABEC 2011, Darwin, Australia, 14-18 August (2011)

38. E. Bezak, R. Takam, S. Bensaleh, E. Yeoh, L. Marcu

Investigation of normal tissue complication probabilities in prostate and partial-breast irradiation radiotherapy techniques EPSM-ABEC 2011, Darwin, Australia, 14-18 August (2011)

39. L. Marcu, R. Gowda, E. Yeoh

Comparison of three different post implant dosimetry methods following permanent I-125 prostate seed implants 20th Scientific Meeting of the Australasian Brachytherapy Group (ABG), Perth, 28-30 April, Australia (2011)

11

40. L. Marcu, S. Filip The emerging role of PET/CT in optimizing radiotherapy outcome: a Monte Carlo modelling perspective 3rd International Conference on Sciences Oradea, Romania, 12-14 November (2009)

41. L. Marcu, S. Filip

A multidisciplinary approach in predicting treatment outcome for advanced head and neck cancers 1st International Symposium of Oncologic Imaging Focusing on PET/CT, Băile Felix, Romania, 30-31 October (2009)

42. L. Marcu E. Bezak

Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer 3rd International Conference on Biomaterials and Medical Devices -BiomMedD'2008, Bucharest, Romania, 13-16th November (2008)

43. L. Marcu, K. Quach, S. Filip

Gold fiducial markers in prostate cancer brachytherapy 3rd International Conference on Biomaterials and Medical Devices - BiomMedD'2008, Bucharest, Romania, 13-16th November (2008)

44. W. Tuckwell, E. Bezak, E. Yeoh, L. Marcu Modelling head and neck cancer oxygenation: individualising radiotherapy through simulation and animal studies MOT meeting, Adelaide, SA (2008)

45. L. Marcu

Science education: the need for an interdisciplinary approach International Conference of Faculty of Sciences, University of Oradea, Romania, Nov (2007)


Monte Carlo modelling of treatment schedules in the radiotherapy of head and neck cancer: overcoming clinical challenges International Conference of Faculty of Sciences, University of Oradea, Romania, Nov (2007)

47. E. Bezak, R. Takam, E. Yeoh, L. Marcu

Risk of rectal second cancer following prostate radiotherapy ESTRO, Barcelona, Spain, September (2007)

48. W Tuckwell, E Bezak, E. Yeoh, L. Marcu

Monte Carlo modelling for hypoxic head and neck squamous cell carcinoma and radiotherapy, ESTRO, Barcelona, Spain, September (2007)

49. R. Takam, E. Bezak, E. Yeoh, L. Marcu

Rectal Normal Tissue Complication Probability after Prostate Radiotherapy 12th International Conference on Optimal Use of Advanced Radiotherapy in Multimodality Oncology, Nucletron, Rome, Italy, July (2007)

50. W Tuckwell, L Marcu, E Bezak

Individualising radiotherapy planning through Monte Carlo modelling of radiobiological principles for head and neck carcinoma, EPSM, Noosa, Australia, September (2006)

51. W Tuckwell, L Marcu, E Bezak

12

Temporal tumour modelling for individualized RT planning of head and neck cancer AINSE Meeting, Sydney, NSW, Australia, April (2006)

52. L Marcu, K Quach, E Yeoh, R Gowda, D Steele, S Chryssidis

Is post-implant dosimetry a reliable check tool for the quality of prostate implants?, Australian Brachytherapy Group Meeting, Adelaide, SA, Australia, April (2006)


Patient dose due to electronic portal imaging ICTR, Lugano, Switzerland, March (2006)


Radiobiological modelling of the interplay between accelerated repopulation and altered fractionation schedules in head and neck cancers ICTR, Lugano, Switzerland, March (2006)

55. W. Tuckwell, T van Doorn, L. Marcu

Temporal tumour modelling for individualised RT planning of head and neck cancer EPSM, Adelaide, SA, October (2005)

56. L. Marcu, K. Quach

Post-implant dosimetry for I-125 prostate implants: multi-observer intercomparison, EPSM, Adelaide, South Australia, October (2005)


The effect of accelerated repopulation on altered fractionation schedules in head and neck cancers, EPSM, Adelaide, SA, October (2005)


EPI Patient Dose – Something to Worry About? 3rd Annual Australia-New Zealand, Varis Vision User’s Group Meeting, Ballarat, Victoria, July (2005)

59. T van Doorn, L. Marcu, I. Olver, E. Bezak, E. Yeoh, R. Coad

Physical modelling of tumour growth and treatment MOT Meeting, Adelaide, SA, May (2004)

60. L. Marcu, AB Lyons, T van Doorn, E. Bezak

The mechanisms and the onset of accelerated repopulation of radiotherapy stimulated squamous cell carcinoma MOT Meeting, Adelaide, SA, May (2004)

61. L. Marcu, T van Doorn, E. Bezak, I. Olver

Tumour resistance to cisplatin: a modelling approach MOT Meeting, Adelaide, SA, May (2004)


Cell recruitment in tumour regrowth during radiotherapy: a modelling approach, Medical Physics World Congress, Sydney, NSW, August (2003)

63. L. Marcu

Radiotherapy treatment of a virtual head and neck tumour by Monte Carlo simulation Institute of Medical and Veterinary Science and The Hanson Institute for Cancer Research, Adelaide, July (2003)

13

64. L. Marcu, T van Doorn, I. Olver, S. Zavgorodni Recruitment and stem cell cycle duration in accelerated repopulation of radiotherapy stimulated squamous cell carcinoma ICTR, Lugano, Switzerland, March (2003)

65. T van Doorn, L. Marcu, I. Olver, S. Zavgorodni

Inter-relation of biological parameters in the computer simulation of the temporal development of a head and neck tumour ICTR, Lugano, Switzerland, March (2003)

66. L. Marcu

Accelerated repopulation of radiotherapy stimulated squamous cell carcinoma ACPSEM postgraduate annual meeting, Adelaide (2003)

67. L. Marcu

Modelling of tumour growth and radiotherapy The Hanson Institute for Cancer Research, Adelaide (2003)

68. L. Marcu, T van Doorn, I. Olver, S. Zavgorodni

Monte Carlo simulation of the radiotherapy of a virtual head and neck tumour EPSM, Rotorua, New Zealand, November (2002)

69. L. Marcu

Simulation of conventional radiotherapy on head and neck cancers ACPSEM postgraduate annual meeting, Adelaide (2002)


Radiotherapy treatment of a virtual head and neck tumour by Monte Carlo simulation Medical Grand Round, Royal Adelaide Hospital, Adelaide (2002)

71. L. Marcu

Growth of a virtual tumour using Monte Carlo modelling ACPSEM postgraduate annual meeting, Adelaide, South Australia (2001)


Computer simulation of tumour growth and cellular phase distribution prior to chemoradiotherapy EPSM, Fremantle, Western Australia, September-October (2001)


Fractionation and delivery schedules in combined radiotherapy-cisplatin for head and neck cancer Australian Institute of Physics Conference, Adelaide, SA, December (2000)

loredana g. marcu, phd - fizicaoradea.ro · 2016-09-23 · 5. l. marcu, e. bezak (editors) recent...

Documents